Mucosal assessment of tumor necrosis factor alpha levels on paraffined samples: A comparison between immunohistochemistry and real time polymerase chain reaction

Scandinavian Journal of Gastroenterology

Volumn 45, Issue 7-8, 2010, Pages 1007-1008

  Ierardi, Enzo ^a   Giorgio, Floriana ^a   Rosania, Rosa ^a   Zotti, Mariangela ^a   Prencipe, Simonetta ^a   Della Valle, Nicola ^a   De Francesco, Vincenzo ^a   Panella, Carmine ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PARAFFIN; TUMOR NECROSIS FACTOR ALPHA;

AGE DISTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; CROHN DISEASE; DISEASE COURSE; ENDOSCOPIC BIOPSY; ENTERITIS; GENE EXPRESSION; GENE SYNTHESIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTESTINE MUCOSA; IRRITABLE COLON; LETTER; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEX RATIO; STOMACH MUCOSA LESION; THERAPY EFFECT; ULCERATIVE COLITIS;

FEMALE; HUMANS; INTESTINAL MUCOSA; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77955695110     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2010.483739     Document Type: Letter

References (8)

1. Plevy SE, Landers CJ, Prehn J, Carramanzana NM, Deem RL, Shealy D, Targan SR. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J Immunol 1997;159:6276-6282
2. Olsen T, Goll R, Cui G, Husebekk A, Vonen B, Birketvedt GS, Florholmen J. Tissue levels of tumor necrosis factor-alpha correlateswith grade of inflammation in untreated ulcerative colitis. Scand J Gastroenterol 2007;42:1312-1320
3. Baert FJ, D'Haens GR, Peeters M, Hiele MI, Schaible TF, Shealy D, Geboes K, Rutgeerts PJ. Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammationinCrohn's ileocolitis. Gastroenterology 1999; 116:22-28
4. Olsen T, Cui G, Goll R, Husebekk A, Florholmen J. Infliximab therapy decreases the levels of TNF-alpha and IFNgamma mRNA in colonic mucosa of ulcerative colitis. Scand J Gastroenterol 2009;44:727-735
5. Ierardi E, Monno RA, Gentile A, Francavilla R, Burattini O, Marangi S, Pollice L, Francavilla A. Helicobacter heilmannii gastritis: a histological and immunohistochemical trait. J Clin Pathol 2001;54:774-777
6. Bustin SA. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000;25:169-193
7. Principi M, Day R, Marangi S, Burattini O, De Francesco V, Ingrosso M, et al. Differential immunohistochemical expression of syndecan-1 and tumor necrosis factor alpha in colonic mucosa of patients with Crohn's disease. Immunopharmacol Immunotoxicol 2006;28:185-195
8. Hassan C, Ierardi E, Burattini O, De Francesco V, Zullo A, StoppinoG,et al.Tumournecrosis factor alphadown-regulation parallels inflammatory regression in ulcerative colitis patients treated with infliximab. Dig Liver Dis 2007;39:811-817